Genetic polymorphisms near IL-21 gene associated with Th17 cytokines confer risk for systemic lupus erythematosus in Chinese Han population.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 406, doi. 10.1177/0961203319829821
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2019 AND VI 28 AND IP 3
Results: 24
1
2
Antibodies to M-type phospholipase A2 receptor (PLA<sub>2</sub>R) in membranous lupus nephritis.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 396, doi. 10.1177/0961203319828521
- By:
- Publication type:
- Article
3
Anti–α-enolase antibody combined with β2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 365, doi. 10.1177/0961203319828822
- By:
- Publication type:
- Article
4
Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 414, doi. 10.1177/0961203319828818
- By:
- Publication type:
- Article
5
Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 383, doi. 10.1177/0961203319828527
- By:
- Publication type:
- Article
6
Effect of pericardial effusion on outcomes in children admitted with systemic lupus erythematosus: a multicenter retrospective cohort study from the United States.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 389, doi. 10.1177/0961203319828523
- By:
- Publication type:
- Article
7
Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 334, doi. 10.1177/0961203319829817
- By:
- Publication type:
- Article
8
Genomewide analysis of 6-methyladenine DNA in peripheral blood mononuclear cells of systemic lupus erythematosus.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 359, doi. 10.1177/0961203319828520
- By:
- Publication type:
- Article
9
The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 371, doi. 10.1177/0961203319828519
- By:
- Publication type:
- Article
10
Induced expression of Toll-like receptor 9 in peritubular capillary endothelium correlates with the progression of tubulointerstitial lesions in autoimmune disease-prone mice.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 324, doi. 10.1177/0961203319828518
- By:
- Publication type:
- Article
11
The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 347, doi. 10.1177/0961203319828509
- By:
- Publication type:
- Article
12
Levels of anti-Müllerian hormone in premenopausal women with the antiphospholipid syndrome and its association with the risk of clinical complications.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 427, doi. 10.1177/0961203319828507
- By:
- Publication type:
- Article
13
Pulmonary hypertension in lupus.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
14
Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 304, doi. 10.1177/0961203319827646
- By:
- Publication type:
- Article
15
Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 290, doi. 10.1177/0961203319826704
- By:
- Publication type:
- Article
16
Early-stage predictors for treatment responses in patients with active lupus nephritis.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 283, doi. 10.1177/0961203319826703
- By:
- Publication type:
- Article
17
Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 265, doi. 10.1177/0961203319826695
- By:
- Publication type:
- Article
18
Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 423, doi. 10.1177/0961203319826693
- By:
- Publication type:
- Article
19
Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 295, doi. 10.1177/0961203319826690
- By:
- Publication type:
- Article
20
Incidence and predictors of aorta calcification in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 275, doi. 10.1177/0961203319826689
- By:
- Publication type:
- Article
21
Hydroxychloroquine: do we all see eye to eye? A single-site analysis of hydroxychloroquine dosing compared with the 2016 Revision of the American Academy of Ophthalmology guidelines.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 438, doi. 10.1177/0961203319826682
- By:
- Publication type:
- Article
22
Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 317, doi. 10.1177/0961203319826672
- By:
- Publication type:
- Article
23
‘Seronegative antiphospholipid syndrome’: an update.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 273, doi. 10.1177/0961203319826358
- By:
- Publication type:
- Article
24
Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review.
- Published in:
- Lupus, 2019, v. 28, n. 3, p. 432, doi. 10.1177/0961203319825570
- By:
- Publication type:
- Article